InMed Pharmaceuticals, Inc. (INM)
1.305
+0.02
(+1.16%)
USD |
NASDAQ |
Sep 14, 16:00
1.305
0.00 (0.00%)
After-Hours: 16:31
InMed Pharmaceuticals Price : 1.305 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 1.33 | 1.35 | 1.29 | 1.29 | 28135.00 |
| Sep 10, 2026 | 1.31 | 1.34 | 1.29 | 1.31 | 20500.00 |
| Sep 09, 2026 | 1.310 | 1.33 | 1.28 | 1.31 | 52816.00 |
| Sep 08, 2026 | 1.36 | 1.39 | 1.31 | 1.33 | 63669.00 |
| Sep 04, 2026 | 1.339 | 1.397 | 1.33 | 1.38 | 9542.00 |
| Sep 03, 2026 | 1.341 | 1.41 | 1.32 | 1.33 | 45539.00 |
| Sep 02, 2026 | 1.36 | 1.40 | 1.33 | 1.35 | 19980.00 |
| Sep 01, 2026 | 1.35 | 1.35 | 1.30 | 1.32 | 104483.0 |
| Aug 31, 2026 | 1.36 | 1.42 | 1.35 | 1.35 | 90046.00 |
| Aug 28, 2026 | 1.425 | 1.43 | 1.38 | 1.38 | 111947.0 |
| Aug 27, 2026 | 1.422 | 1.45 | 1.405 | 1.43 | 29818.00 |
| Aug 26, 2026 | 1.48 | 1.48 | 1.36 | 1.43 | 60915.00 |
| Aug 25, 2026 | 1.44 | 1.47 | 1.385 | 1.44 | 118474.0 |
| Aug 24, 2026 | 1.48 | 1.61 | 1.41 | 1.43 | 164410.0 |
| Aug 21, 2026 | 1.58 | 1.615 | 1.45 | 1.46 | 71608.00 |
| Aug 20, 2026 | 1.57 | 1.65 | 1.54 | 1.58 | 63936.00 |
| Aug 19, 2026 | 1.46 | 1.632 | 1.45 | 1.59 | 86112.00 |
| Aug 18, 2026 | 1.49 | 1.64 | 1.44 | 1.44 | 269128.0 |
| Aug 17, 2026 | 1.47 | 1.54 | 1.430 | 1.46 | 73930.00 |
| Aug 14, 2026 | 1.448 | 1.50 | 1.44 | 1.47 | 40717.00 |
| Aug 13, 2026 | 1.45 | 1.458 | 1.410 | 1.43 | 23996.00 |
| Aug 12, 2026 | 1.45 | 1.48 | 1.41 | 1.44 | 38615.00 |
| Aug 11, 2026 | 1.43 | 1.47 | 1.40 | 1.46 | 56585.00 |
| Aug 10, 2026 | 1.35 | 1.500 | 1.35 | 1.41 | 130835.0 |
| Aug 07, 2026 | 1.43 | 1.485 | 1.42 | 1.47 | 54554.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 2.19 |
| Milestone Pharmaceuticals, Inc. | 0.9505 |
| Clearmind Medicine, Inc. | 0.92 |
| Lexaria Bioscience Corp. | 3.51 |
| Target Group, Inc. (Canada) | 0.0011 |
Price Related Metrics
| PS Ratio | 2.746 |
| Price to Book Value | 6.482 |
| Earnings Yield | -238.8% |
| Market Cap | 6.968M |